Introduction: Online Diabetes Prevention Programs (DPPs) can be scaled up and delivered broadly. However, little is known about real-world effectiveness and how outcomes compare with in-person DPP. This study examined online DPP weight loss and participation outcomes and secondarily compared outcomes among participating individuals with parallel in-person interventions.

Study Design: A large non-randomized trial supplemented by a comparative analysis of participating individuals from a concurrent trial of two parallel in-person programs: in-person DPP and the Veterans Administration's standard of care weight loss program (MOVE!).

Setting/participants: Obese/overweight Veterans with prediabetes enrolled in online DPP (n = 268) between 2013 and 2014. Similar eligibility criteria were used to enroll in-person participants between 2012 and 2014 (n = 273 in-person DPP, n = 114 MOVE!) within a separate trial.

Intervention: Online DPP included a virtual group format, live e-coach, weekly modules delivered asynchronously, and wireless home scales. In-person programs included eight to 22 group-based, face-to-face sessions.

Main Outcomes Measures: Weight change at 6 and 12 months using wirelessly uploaded home scale data or electronic medical record weights from clinical in-person visits. Outcomes were analyzed between 2015 and 2017.

Results: From 1,182 invitations, 268 (23%) participants enrolled in online DPP. Among these, 158 (56%) completed eight or more modules; mean weight change was -4.7kg at 6 months and -4.0kg at 12 months. In a supplemental analysis of participants completing one or more sessions/modules, online DPP participants were most likely to complete eight or more sessions/modules (87% online DPP vs 59% in-person DPP vs 55% MOVE!, p < 0.001). Online and in-person DPP participants lost significantly more weight than MOVE! participants at 6 and 12 months; there was no significant difference in weight change between online and in-person DPP.

Conclusions: An intensive, multifaceted online DPP intervention had higher participation but similar weight loss compared to in-person DPP. An intensive, multifaceted online DPP intervention may be as effective as in-person DPP and help expand reach to those at risk.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699502PMC
http://dx.doi.org/10.1016/j.amepre.2018.06.028DOI Listing

Publication Analysis

Top Keywords

online dpp
24
in-person dpp
16
dpp
10
in-person
9
online diabetes
8
diabetes prevention
8
weight loss
8
participating individuals
8
parallel in-person
8
in-person programs
8

Similar Publications

Article Synopsis
  • - Diabetes Mellitus poses a significant public health challenge globally, particularly in low- and middle-income countries like Nepal, where medication costs hinder patient access to necessary treatments.
  • - A study investigated price variations in oral hypoglycaemic medicines (OHMs) across Nepal, finding a dramatic maximum variation of 484.82%, with many medicine categories surpassing 100% price differences despite the local production of these drugs.
  • - The findings highlight a lack of cost-effective alternatives and suggest a need for better drug policies to make OHMs more affordable, ensuring patients have access without financial strain.
View Article and Find Full Text PDF

Alogliptin is an oral hypoglycemic agent selective inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. Inhibition of DPP-4 increases the levels of the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) by preventing their degradation. The main goal is to study the predicted and experimental properties of absorption, distribution, metabolism, and elimination (ADME), compare them, examine predicted targets, and understand the use of SwissADME in designing other drug molecules.

View Article and Find Full Text PDF

Background: Exposures to endocrine disrupting chemicals (EDCs) have been linked to chronic diseases including breast cancer, metabolic syndrome, diabetes, and infertility. Exposure during pregnancy may have a lifelong impact on the fetus. Services are needed to allow individuals to learn about their personal EDC exposures and how to reduce them.

View Article and Find Full Text PDF

Background Individuals with prediabetes are at an increased risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular diseases and mortality from any cause. The treatment and early detection of prediabetes and T2DM can aid in the prevention of future health complications. The aim of this research was to assess the attitude, knowledge, and practices of family medicine (FM) residents in Saudi Arabia regarding prediabetes.

View Article and Find Full Text PDF

Introduction: The Diabetes Prevention Program (DPP) is effective; enrollment is low. Little research has examined factors driving individuals' enrollment decisions.

Methods: In our final survey of a randomized trial comparing methods to increase enrollment in the DPP, we asked participants about factors impacting enrollment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!